Balancing Our Microbiome
Dr. Kamada focuses on the bad actors of the microbiome—bacterial troublemakers that contribute to IBD pathogenesis.
Researchers
Below are researchers funded by the Kenneth Rainin Foundation who are working in the microbiome.
Nobuhiko Kamada, PhD
Professor, University of Michigan, Former Grantee
Dr. Kamada’s lab investigates how gut microbiota and host immunity interact in gastrointestinal health and disease. Their focus is on the mechanism by which certain pathogenic members of commensal bacteria promote chronic intestinal inflammation that leads…
Maia Kayal, MD
Assistant Professor, Icahn School of Medicine at Mount Sinai, Current Grantee
Dr. Kayal specializes in the care of patients with gastrointestinal illnesses with a focus on ulcerative colitis and Crohn’s disease. Her current research interests include prediction and risk stratification in ulcerative colitis patients who need surgery.
Meghan Koch, PhD
Assistant Professor, Fred Hutchinson Cancer Research Center, Current Grantee
The Koch lab studies maternal-fetal interactions, focusing on immunity, metabolism and the microbiota. They are working to identify novel pathways through which maternal-offspring interactions regulate neonatal health.
Ta-Chiang Liu, MD, PhD
Associate Professor, Washington University in St. Louis, Former Grantee
The Liu lab is interested in the molecular mechanisms of how morphologic patterns of cytoplasmic antimicrobial granules are affected by genetics and environmental triggers, and their clinical relevance.
Carrie Lucas, PhD
Associate Professor, Yale University, Former Grantee
The Lucas lab strives to discover mechanisms of disease driving rare immune disorders, focusing on the genetic, cellular and biochemical underpinnings that can illuminate fundamental biology and broadly inform diagnoses and treatments.
Susan Lynch, PhD
Professor; University of California, San Francisco; Former Grantee
The Lynch lab focuses primarily on the human microbiota in both respiratory and gastrointestinal tracts, environmental microbial exposures that shape its development and its role in chronic inflammatory diseases.
